Yao C, Levy RH. Inhibition-based metabolic drug–drug interactions: predictions from
in vitrodata. J Pharm Sci 2002;91:1923–1935.
Yao M, Zhu M, Sinz MW, Zhang H, Humphreys WG, Rodrigues AD, Dai R.
Development and full validation of six inhibition assays for the five major
cytochrome P450 enzymes in human liver microsomes using an automated 96-well
microplate incubation format and LC-MS/MS analysis. J Pharm Biomed Anal
2007;44:211–223.
Yin H, Racha J, Li SY, Olejnik N, Satoh H, Moore D. Automated high throughput
human CYP isoform activity assay using SPE-LC/MS method: application in CYP
inhibition evaluation. Xenobiotica 2000;30:141–154.
Zhang L, Strong JM, Qiu W, Lesko LJ, Huang SM. Scientific perspectives on drug
transporters and their role in drug interactionst. Mol Pharm 2006;3:62–69.
Zhang T, Zhu Y, Gunaratna C. Rapid and quantitative determination of metabolites
from multiple cytochrome P450 probe substrates by gradient liquid chromatography-
electrospray ionization-ion trap mass spectrometry. J Chromatogr B Analyt Technol
Biomed Life Sci 2002;780:371–379.
544 ANALYSIS OFIN VITROCYTOCHROME P450 INHIBITION